PUBLISHER: Polaris Market Research | PRODUCT CODE: 1478598
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1478598
Europe Facial Injectable Market Share, Size, Trends, Industry Analysis Report, By Product; By Application; By End-use; By Country; Segment Forecast, 2024 - 2032
The Europe facial injectable market size is expected to reach USD 7.33 billion by 2032, according to a new study by Polaris Market Research. The report "Europe Facial Injectable Market Share, Size, Trends, Industry Analysis Report, By Product (Collagen & PMMA Microspheres, Botulinum Toxin Type A, Hyaluronic Acid (HA), Calcium Hydroxylapatite (CaHA), Poly-L-lactic Acid (PLLA), and Others); By Application; By End-use; By Country; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Market expansion is due to an increase in awareness related to the benefits of facial injectables, innovation in facial injectables, and investments in the aesthetic industry. As individuals age, they experience various changes in their facial appearance, such as the development of wrinkles, fine lines, volume loss, and sagging skin. Facial injectables offer non-surgical solutions to address these signs of aging, providing patients with rejuvenated skin. As a result, the aging population is an additional factor driving the facial injectable market growth across European countries.
For instance, according to a report published by the World Health Organization (WHO), the European population aged 60 and older numbered 215 million in 2021 and is expected to reach 247 million by 2030.
Consumers are increasingly seeking alternatives to surgical treatments for changes in facial appearance. Moreover, key players operating in the facial injectable market are continuously developing new formulations and delivery techniques to improve the efficiency, safety, and longevity of injectable products. Hence, these advancements in cosmetic procedures have also contributed to the growing acceptance of dermal fillers among consumers, further driving growth.
A rise in cases of successful completion of clinical trials according to quality and safety standards will boost the demand for facial injectables, in turn increasing the market growth. For instance, in December 2023, Teoxane received a Medical Device Regulation (MDR) certification for its entire product portfolio. Similarly, in June 2023, Galderma received FDA approval for its newest hyaluronic acid filler, Restylane Eyelight. Also, in September 2023, Belotero Balance (+), manufactured by Merz Aesthetics, received FDA approval for the correction of moderate-severe facial wrinkles and folds.
The cost of these treatments may vary depending on the type of injectable used. For instance, according to the data published by the UK Health Centre, the cost of Juvederm starts at around USD 345 in the UK. Similarly, Restylane treatment costs between USD 250 - 500 in the UK. Thus, the high cost of these injectables is likely to deter the market growth. However, technological advancements have resulted in the development of affordable facial injectables without compromising their effectiveness.
Europe Facial Injectable Market Report Highlights
The Botulinum Toxin Type A segment will grow rapidly, attributed to its versatility, efficacy, and minimally invasive nature of the product.
The facial line correction segment held the largest revenue share, owing to the rapid growth of elderly population.
The MedSpa segment dominated the market due to the surge in demand for cosmetic procedures.
Germany dominated the market, owing to the rise in awareness related to the benefits of facial injectables.
Key players include Galderma, Merz GmbH, Revance Therapeutics, Ispen, Zimmer Aesthetics, AbbVie, Sinclair Pharma, and Teoxane.
Polaris Market Research has segmented the Europe facial injectables market report based on product, application, end-use, and country:
Europe Facial Injectable, Product Outlook (Revenue - USD Billion, 2019 - 2032)
- Collagen & PMMA Microspheres
- Botulinum Toxin Type A
- Hyaluronic Acid (HA)
- Calcium Hydroxylapatite (CaHA)
- Poly-L-lactic Acid (PLLA)
- Others
Europe Facial Injectable, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Facial Line Correction
- Lip Augmentation
- Face Lift
- Acne Scar Treatment
- Lipoatrophy Treatment
- Others
Europe Facial Injectable, End-use Outlook (Revenue - USD Billion, 2019 - 2032)
- MedSpa
- Dermatology Clinics
- Hospitals
Europe Facial Injectable, Country Outlook (Revenue - USD Billion, 2019 - 2032)
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
Table of Contents
1.Introduction
- 1.1.Report Description
- 1.1.1.Objectives of the Study
- 1.1.2.Market Scope
- 1.1.3.Assumptions
- 1.2.Stakeholders
2.Executive Summary
- 2.1.Market Highlights
3.Research Methodology
- 3.1.Overview
- 3.1.1.Data Mining
- 3.2.Data Sources
- 3.2.1.Primary Sources
- 3.2.2.Secondary Sources
4.Europe Facial Injectable Market Insights
- 4.1.Europe Facial Injectable Market - Industry Snapshot
- 4.2.Europe Facial Injectable Market Dynamics
- 4.2.1.Drivers and Opportunities
- 4.2.1.1.Increasing demand for non-surgical procedures
- 4.2.1.2.Innovation and advancements in injectable technologies
- 4.2.2.Restraints and Challenges
- 4.2.2.1.Regulatory hurdles
- 4.2.1.Drivers and Opportunities
- 4.3.Porter's Five Forces Analysis
- 4.3.1.Bargaining Power of Suppliers (Moderate)
- 4.3.2.Threats of New Entrants: (Low)
- 4.3.3.Bargaining Power of Buyers (Moderate)
- 4.3.4.Threat of Substitute (Moderate)
- 4.3.5.Rivalry among existing firms (High)
- 4.4.PESTLE Analysis
- 4.5.Europe Facial Injectable Industry trends
- 4.6.Value Chain Analysis
- 4.7.COVID-19 Impact Analysis
5.Europe Facial Injectable Market, by Product
- 5.1.Key Findings
- 5.2.Introduction
- 5.2.1.Europe Facial Injectable, by Product, 2019-2032 (USD Million)
- 5.3.Collagen & PMMA Microspheres
- 5.3.1.Europe Facial Injectable Market, by Collagen & PMMA Microspheres, 2019-2032 (USD Million)
- 5.4.Botulinum Toxin Type A
- 5.4.1.Europe Facial Injectable Market, by Botulinum Toxin Type A, 2019-2032 (USD Million)
- 5.5.Hyaluronic Acid (HA)
- 5.5.1.Europe Facial Injectable Market, by Hyaluronic Acid (HA), 2019-2032 (USD Million)
- 5.6.Calcium Hydroxylapatite (CaHA)
- 5.6.1.Europe Facial Injectable Market, by Calcium Hydroxylapatite (CaHA), 2019-2032 (USD Million)
- 5.7.Poly-L-lactic Acid (PLLA)
- 5.7.1.Europe Facial Injectable Market, by Poly-L-lactic Acid (PLLA), 2019-2032 (USD Million)
- 5.8.Others
- 5.8.1.Europe Facial Injectable Market, by Others, 2019-2032 (USD Million)
6.Europe Facial Injectable Market, by Application
- 6.1.Key Findings
- 6.2.Introduction
- 6.2.1.Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- 6.3.Facial Line Correction
- 6.3.1.Europe Facial Injectable Market, by Facial Line Correction, 2019-2032 (USD Million)
- 6.4.Lip Augmentation
- 6.4.1.Europe Facial Injectable Market, by Lip Augmentation, 2019-2032 (USD Million)
- 6.5.Face Lift
- 6.5.1.Europe Facial Injectable Market, by Face Lift, 2019-2032 (USD Million)
- 6.6.Acne Scar Treatment
- 6.6.1.Europe Facial Injectable Market, by Acne Scar Treatment, 2019-2032 (USD Million)
- 6.7.Lipoatrophy Treatment
- 6.7.1.Europe Facial Injectable Market, by Lipoatrophy Treatment, 2019-2032 (USD Million)
- 6.8.Others
- 6.8.1.Europe Facial Injectable Market, by Others, 2019-2032 (USD Million)
7.Europe Facial Injectable Market, by End-Use
- 7.1.Key Findings
- 7.2.Introduction
- 7.2.1.Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- 7.3.MedSpa
- 7.3.1.Europe Facial Injectable Market, by MedSpa, 2019-2032 (USD Million)
- 7.4.Dermatology Clinics
- 7.4.1.Europe Facial Injectable Market, by Dermatology Clinics, 2019-2032 (USD Million)
- 7.5.Hospitals
- 7.5.1.Europe Facial Injectable Market, by Hospitals, 2019-2032 (USD Million)
8.Europe Facial Injectable Market, by Countries
- 8.1.Key findings
- 8.2.Introduction
- 8.2.1.Europe Facial Injectable Market Assessment, By Countries, 2019-2032 (USD Million)
- 8.2.2.Europe Facial Injectable Market - Germany
- 8.2.2.1.Germany: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- 8.2.2.2.Germany: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- 8.2.2.3.Germany: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- 8.2.3.Europe Facial Injectable Market - Italy
- 8.2.3.1.Italy.: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- 8.2.3.2.Italy.: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- 8.2.3.3.Italy.: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- 8.2.4.Europe Facial Injectable Market - Spain
- 8.2.4.1.Spain: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- 8.2.4.2.Spain: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- 8.2.4.3.Spain: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- 8.2.5.Europe Facial Injectable Market - UK
- 8.2.5.1.UK: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- 8.2.5.2.UK: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- 8.2.5.3.UK: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- 8.2.6.Europe Facial Injectable Market - France
- 8.2.6.1.France: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- 8.2.6.2.France: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- 8.2.6.3.France: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- 8.2.7.Europe Facial Injectable Market - Russia
- 8.2.7.1.Russia: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- 8.2.7.2.Russia: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- 8.2.7.3.Russia: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- 8.2.8.Europe Facial Injectable Market - Rest of Europe
- 8.2.8.1.Rest of Europe: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- 8.2.8.2.Rest of Europe: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- 8.2.8.3.Rest of Europe: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- 8.2.9.Europe Facial Injectable Market - Netherlands
- 8.2.9.1.Netherlands: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- 8.2.9.2.Netherlands: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- 8.2.9.3.Netherlands: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
9.Competitive Landscape
- 9.1.Expansion and Acquisition Analysis
- 9.1.1.Expansion
- 9.1.2.Acquisitions
- 9.2.Partnerships/Collaborations/Agreements/Exhibitions
10.Company Profiles
- 10.1.Abbvie (U.S.)
- 10.1.1.Company Overview
- 10.1.2.Financial Performance
- 10.1.3.Product Benchmarking
- 10.1.4.Recent Development
- 10.2.Galderma (Switzerland)
- 10.2.1.Company Overview
- 10.2.2.Financial Performance
- 10.2.3.Product Benchmarking
- 10.2.4.Recent Development
- 10.3.Ispen (France)
- 10.3.1.Company Overview
- 10.3.2.Financial Performance
- 10.3.3.Product Benchmarking
- 10.3.4.Recent Development
- 10.4.Merz GmbH and Co. KGaA (Germany)
- 10.4.1.Company Overview
- 10.4.2.Financial Performance
- 10.4.3.Product Benchmarking
- 10.4.4.Recent Development
- 10.5.Revance Therapeutics, Inc. (U.S.)
- 10.5.1.Company Overview
- 10.5.2.Financial Performance
- 10.5.3.Product Benchmarking
- 10.5.4.Recent Development
- 10.6.Sinclair Pharma (UK)
- 10.6.1.Company Overview
- 10.6.2.Financial Performance
- 10.6.3.Product Benchmarking
- 10.6.4.Recent Development
- 10.7.Teoxane (Switzerland)
- 10.7.1.Company Overview
- 10.7.2.Financial Performance
- 10.7.3.Product Benchmarking
- 10.7.4.Recent Development
- 10.8.Zimmer Aesthetics (Germany)
- 10.8.1.Company Overview
- 10.8.2.Financial Performance
- 10.8.3.Product Benchmarking
- 10.8.4.Recent Development
List of Tables
- Table 1 Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- Table 2 Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- Table 3 Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- Table 4 Europe Facial Injectable Market Assessment, By Countries, 2019-2032 (USD Million)
- Table 5 Germany: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- Table 6 Germany: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- Table 7 Germany: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- Table 8 Italy.: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- Table 9 Italy.: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- Table 10 Italy.: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- Table 11 Spain: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- Table 12 Spain: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- Table 13 Spain: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- Table 14 UK: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- Table 15 UK: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- Table 16 UK: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- Table 17 France: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- Table 18 France: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- Table 19 France: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- Table 20 Germany: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- Table 21 Germany: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- Table 22 Germany: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- Table 23 Russia: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- Table 24 Russia: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- Table 25 Russia: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- Table 26 Rest of Europe: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- Table 27 Rest of Europe: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- Table 28 Rest of Europe: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
- Table 29 Netherlands: Europe Facial Injectable Market, by Application, 2019-2032 (USD Million)
- Table 30 Netherlands: Europe Facial Injectable Market, by Product, 2019-2032 (USD Million)
- Table 31 Netherlands: Europe Facial Injectable Market, by End-Use, 2019-2032 (USD Million)
List of Figures
- Figure 1 Europe Facial Injectable Market, 2019-2032 (USD Million)
- Figure 2 Integrated Ecosystem
- Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4 Market by Countries
- Figure 5 Porter's Five Forces
- Figure 6 Market by Application
- Figure 7 Europe Facial Injectable Market, by Application, 2024 & 2032 (USD Million)
- Figure 8 Market by Product
- Figure 9 Europe Facial Injectable Market, by Product, 2024 & 2032 (USD Million)
- Figure 10 Market by End-Use
- Figure 11 Europe Facial Injectable Market, by End-Use, 2024 & 2032 (USD Million)
- Figure 12 Europe Facial Injectable Market Assessment, By Countries, 2024 & 2032 (USD Million)
- Figure 13 Strategic Analysis - Europe Facial Injectable Market
